3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Breast
1
Conditions
Wounds and Injuries
1
Non-Melanoma Skin Cancers
1
Keratosis, Actinic
1
Head and Neck Neoplasms
1
Cancer Pain
1
Breast Neoplasms
1
Interventions
Pharmaceutical Services
2
Lidocaine
2
Ethanol
2
Acetaminophen
2
Venlafaxine Hydrochloride
1
Ropivacaine
1
Radiofrequency Ablation
1
Pregabalin
1
Oxycodone
1
Myofascial Release Therapy
1
Morphine
1
Methadone
1
Memantine
1
Ketamine
1
Hospitals
1
Gels
1
Dronabinol
1
Cholecalciferol
1
Calcium Dobesilate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Cancer Pain
×
Gels
×
Clear all
NCT05800834
2023-09-28
MorphineGEL
Instituto Nacional de Cancer, Brazil
Phase 2
Unknown
106 enrolled